搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Nitrosomonas eutropha Ribonuclease HII (rnhB) CSB-YP601473NAAD
CSB-EP601473NAAD
CSB-BP601473NAAD
CSB-MP601473NAAD
CSB-EP601473NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Chorismate synthase (aroC) CSB-YP601474NAAD
CSB-EP601474NAAD
CSB-BP601474NAAD
CSB-MP601474NAAD
CSB-EP601474NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Probable glycine dehydrogenase [decarboxylating] subunit 1 (gcvPA) CSB-YP601475NAAD
CSB-EP601475NAAD
CSB-BP601475NAAD
CSB-MP601475NAAD
CSB-EP601475NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Phosphoribosyl-AMP cyclohydrolase (hisI) CSB-YP601476NAAD
CSB-EP601476NAAD
CSB-BP601476NAAD
CSB-MP601476NAAD
CSB-EP601476NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Adenosylhomocysteinase (ahcY) CSB-YP601477NAAD
CSB-EP601477NAAD
CSB-BP601477NAAD
CSB-MP601477NAAD
CSB-EP601477NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 50S ribosomal protein L1 (rplA) CSB-YP601478NAAD
CSB-EP601478NAAD
CSB-BP601478NAAD
CSB-MP601478NAAD
CSB-EP601478NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Acetyl-coenzyme A synthetase (acsA), partial CSB-YP601479NAAD
CSB-EP601479NAAD
CSB-BP601479NAAD
CSB-MP601479NAAD
CSB-EP601479NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Translation initiation factor IF-2 (infB), partial CSB-YP601480NAAD
CSB-EP601480NAAD
CSB-BP601480NAAD
CSB-MP601480NAAD
CSB-EP601480NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Phosphoglycerate kinase (pgk) CSB-YP601481NAAD
CSB-EP601481NAAD
CSB-BP601481NAAD
CSB-MP601481NAAD
CSB-EP601481NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Leucine--tRNA ligase (leuS) CSB-YP601482
CSB-EP601482
CSB-BP601482
CSB-MP601482
CSB-EP601482-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Ribosomal protein S12 methylthiotransferase RimO (rimO) CSB-YP601483NAAD
CSB-EP601483NAAD
CSB-BP601483NAAD
CSB-MP601483NAAD
CSB-EP601483NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP601484NAAD
CSB-EP601484NAAD
CSB-BP601484NAAD
CSB-MP601484NAAD
CSB-EP601484NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Probable chemoreceptor glutamine deamidase CheD (cheD) CSB-YP601485NAAD
CSB-EP601485NAAD
CSB-BP601485NAAD
CSB-MP601485NAAD
CSB-EP601485NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP601486NAAD
CSB-EP601486NAAD
CSB-BP601486NAAD
CSB-MP601486NAAD
CSB-EP601486NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 4-hydroxybenzoate octaprenyltransferase (ubiA) CSB-YP601487
CSB-EP601487
CSB-BP601487
CSB-MP601487
CSB-EP601487-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha ATP phosphoribosyltransferase regulatory subunit (hisZ) CSB-YP601488NAAD
CSB-EP601488NAAD
CSB-BP601488NAAD
CSB-MP601488NAAD
CSB-EP601488NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha DNA ligase (ligA), partial CSB-YP601489NAAD
CSB-EP601489NAAD
CSB-BP601489NAAD
CSB-MP601489NAAD
CSB-EP601489NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Peptide chain release factor 1 (prfA) CSB-YP601490NAAD
CSB-EP601490NAAD
CSB-BP601490NAAD
CSB-MP601490NAAD
CSB-EP601490NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 30S ribosomal protein S9 (rpsI) CSB-YP601491NAAD
CSB-EP601491NAAD
CSB-BP601491NAAD
CSB-MP601491NAAD
CSB-EP601491NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Flagellar hook-basal body complex protein FliE (fliE) CSB-YP601492NAAD
CSB-EP601492NAAD
CSB-BP601492NAAD
CSB-MP601492NAAD
CSB-EP601492NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>